| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |